Legend Biotech (LEGN) Short Interest Ratio & Short Volume → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free LEGN Stock Alerts $45.16 -1.21 (-2.61%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Legend Biotech Short Interest DataCurrent Short Volume13,280,000 sharesPrevious Short Volume10,980,000 sharesChange Vs. Previous Month+20.95%Dollar Volume Sold Short$580.87 millionShort Interest Ratio / Days to Cover13.5Last Record DateApril 30, 2024Outstanding Shares181,910,000 sharesPercentage of Shares Shorted7.30%Today's Trading Volume566,505 sharesAverage Trading Volume999,232 sharesToday's Volume Vs. Average57% Short Selling Legend Biotech ? Sign up to receive the latest short interest report for Legend Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLEGN Short Interest Over TimeLEGN Days to Cover Over TimeLEGN Percentage of Float Shorted Over Time Ad The Freeport SocietyBill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. Legend Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202413,280,000 shares $580.87 million +21.0%N/A13.5 $43.74 4/15/202410,980,000 shares $567.78 million +9.9%N/A10.9 $51.71 3/31/20249,990,000 shares $560.34 million -5.0%N/A10.2 $56.09 3/15/202410,510,000 shares $672.85 million +2.4%N/A10.8 $64.02 2/29/202410,260,000 shares $668.54 million +3.2%N/A11.1 $65.16 2/15/20249,940,000 shares $567.08 million -1.1%N/A9.7 $57.05 Get the Latest News and Ratings for LEGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Legend Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/31/202410,050,000 shares $553.35 million +0.4%N/A9.8 $55.06 1/15/202410,010,000 shares $608.31 million +0.7%N/A10.4 $60.77 12/31/20239,940,000 shares $598.09 million -7.4%N/A11.5 $60.17 12/15/202310,730,000 shares $657.64 million -0.2%N/A13 $61.29 11/30/202310,750,000 shares $653.82 million +21.1%N/A14.2 $60.82 11/15/20238,880,000 shares $576.93 million +9.2%N/A15.7 $64.97 10/31/20238,130,000 shares $537.15 million -0.4%N/A16.1 $66.07 10/15/20238,160,000 shares $542.64 million +4.8%N/A16.1 $66.50 9/30/20237,790,000 shares $523.25 million +8.0%N/A14.7 $67.17 9/15/20237,210,000 shares $478.38 million -2.8%N/A13.4 $66.35 8/31/20237,420,000 shares $514.65 million +7.2%N/A12.1 $69.36 8/15/20236,920,000 shares $463.29 million +1.6%N/A10 $66.95 7/31/20236,810,000 shares $514.29 million +15.8%N/A9.8 $75.52 7/15/20235,880,000 shares $408.42 million -1.5%N/A7.8 $69.46 6/30/20235,970,000 shares $412.11 million +5.9%N/A6.6 $69.03 6/15/20235,640,000 shares $401.85 million +24.5%N/A6.2 $71.25 5/31/20234,530,000 shares $290.69 million -3.2%N/A5.4 $64.17 5/15/20234,680,000 shares $342.30 million +13.6%N/A5.8 $73.14 4/30/20234,120,000 shares $283.09 million -21.4%N/A5.2 $68.71 4/15/20235,240,000 shares $277.82 million -11.2%N/A6.4 $53.02 3/31/20235,900,000 shares $284.50 million +15.5%N/A9.3 $48.22 3/15/20235,110,000 shares $239.71 million +14.8%N/A8.3 $46.91 2/28/20234,450,000 shares $205.50 million +12.7%N/A6.7 $46.18 2/15/20233,950,000 shares $192.96 million +7.1%N/A6 $48.85 1/31/20233,690,000 shares $186.35 million +0.8%N/A5.5 $50.50 1/15/20233,660,000 shares $209.97 million +1.7%N/A5.4 $57.37 12/30/20223,600,000 shares $179.71 million -19.1%N/A5.2 $49.92 12/15/20224,450,000 shares $230.69 million +13.2%N/A6.4 $51.84 11/30/20223,930,000 shares $202.43 million +6.5%N/A5.4 $51.51 11/15/20223,690,000 shares $193.73 million -38.7%N/A5.2 $52.50 10/31/20226,020,000 shares $299.92 million -13.0%N/A8.6 $49.82 10/15/20226,920,000 shares $275.07 million +2.5%N/A8.7 $39.75 9/30/20226,750,000 shares $275.40 million +22.3%N/A8.8 $40.80 9/15/20225,520,000 shares $240.12 million +22.7%N/A7.3 $43.50Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself LEGN Short Interest - Frequently Asked Questions What is Legend Biotech's current short interest? Short interest is the volume of Legend Biotech shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 13,280,000 shares of LEGN short. Learn More on Legend Biotech's current short interest. What is a good short interest ratio for Legend Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LEGN shares currently have a short interest ratio of 14.0. Learn More on Legend Biotech's short interest ratio. Which institutional investors are shorting Legend Biotech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Legend Biotech: Walleye Trading LLC, PEAK6 Investments LLC, and Goldman Sachs Group Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Legend Biotech's short interest increasing or decreasing? Legend Biotech saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 13,280,000 shares, an increase of 20.9% from the previous total of 10,980,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Legend Biotech's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Legend Biotech: Viking Therapeutics, Inc. (10.98%), Elanco Animal Health Incorporated (2.73%), Cerevel Therapeutics Holdings, Inc. (7.57%), Ascendis Pharma A/S (6.36%), Jazz Pharmaceuticals plc (5.71%), Roivant Sciences Ltd. (8.27%), Intra-Cellular Therapies, Inc. (3.48%), Blueprint Medicines Co. (7.42%), Cytokinetics, Incorporated (13.51%), Catalent, Inc. (3.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Legend Biotech stock? Short selling LEGN is an investing strategy that aims to generate trading profit from Legend Biotech as its price is falling. LEGN shares are trading down $1.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Legend Biotech? A short squeeze for Legend Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LEGN, which in turn drives the price of the stock up even further. How often is Legend Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEGN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: VKTX Short Squeeze ELAN Short Squeeze CERE Short Squeeze ASND Short Squeeze JAZZ Short Squeeze ROIV Short Squeeze ITCI Short Squeeze BPMC Short Squeeze CYTK Short Squeeze CTLT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LEGN) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Next Industry Being Reshaped By AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry